ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Bevacizumab and AZD2171 in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma

This study is currently recruiting participants.
Study NCT00458731.   Last updated on July 23, 2008.   Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Lymphoma
Small Intestine Cancer
2 Additional conditions recognized in this trial
Duodenal Neoplasms
Ileal Neoplasms
Intestinal Neoplasms
Jejunal Neoplasms
Lymphoma, Non-Hodgkin
3 More general conditions related to this trial
Digestive System Diseases
Digestive System Neoplasms
Duodenal Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Ileal Diseases
Immune System Diseases
Immunoproliferative Disorders
Intestinal Diseases
Jejunal Diseases
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
4 Interventions listed in this trial
bevacizumab
cediranib
biopsy
flow cytometry
fluorescent antibody technique
laboratory biomarker analysis
pharmacological study
5 More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Growth Inhibitors
Growth Substances
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
6 Sponsors listed in this trial
M.D. Anderson Cancer Center
National Cancer Institute (NCI)




Links to all studies - primarily for crawlers